Market Overview

BD Gets 510K Clearance for Nasopharyngeal Wash

BD Diagnostics, a segment of BD (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor™ System for Rapid Detection of Flu A+B. This new product is cleared for use in clinical settings.

Posted-In: News FDA

 

Most Popular

Related Articles (BDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters